Table 1.
Participant characteristics and neuropsychological assessment
| Demographic and Cognitive Variables | Healthy controls |
MCI and AD dementia phenotypes |
|---|---|---|
| Overall group | ||
| Mean (SD) | Mean (SD) | |
| Age (y) | 75.6 (7.1) | 67.8 (10.4) |
| Gender (% female) | 50% | 55% |
| Education (y) | 17.9 | 16.5 |
| CDR (%) | 0:100% | 0.5:53.6% |
| 1.0:37.6% | ||
| 2.0:8.7% | ||
| Eotaxin levels (pg/mL) | 156.7 (48.9) | 172.3 (66.1) |
| MCP-1 levels (pg/mL) | 115.1 (19.6) | 102.3 (36.7) |
| IP-10 levels (pg/mL) | 495.4 (301.0) | 542.5 (526.9) |
| MDC levels (pg/mL) | 954.1 (319.6) | 1085.3 (502.0) |
| TARC levels (pg/mL) | 152.3 (155.0) | 190.9 (136.4) |
| MMSE | 29.2 (1.1) | 22.4 (5.4) |
| CVLT-short form 10′ Recall | 7.4 (1.9) | 2.3 (2.6) |
| CVLT-short form D-prime | 3.3 (0.4) | 1.7 (1.0) |
| Benson figure recall | 12.5 (2.1) | 3.8 (3.8) |
Abbreviations: MMSE, mini mental status examination; CVLT, California Verbal Learning Test-II.